PT95338A - Metodo para o tratamento da dor ou de perturbacoes do snc utilizando antagonistas selectivos nos auto-receptores gaba, incluindo derivados de 3,4-di-hidro- ou 1,2,3,4-tetra-hidro-isoquinolina, e processos para a preparacao dos referidos derivados - Google Patents

Metodo para o tratamento da dor ou de perturbacoes do snc utilizando antagonistas selectivos nos auto-receptores gaba, incluindo derivados de 3,4-di-hidro- ou 1,2,3,4-tetra-hidro-isoquinolina, e processos para a preparacao dos referidos derivados

Info

Publication number
PT95338A
PT95338A PT95338A PT9533890A PT95338A PT 95338 A PT95338 A PT 95338A PT 95338 A PT95338 A PT 95338A PT 9533890 A PT9533890 A PT 9533890A PT 95338 A PT95338 A PT 95338A
Authority
PT
Portugal
Prior art keywords
derivatives
gaba
tetrahydro
dihydro
pain
Prior art date
Application number
PT95338A
Other languages
English (en)
Other versions
PT95338B (pt
Inventor
Michael Christopher Wa Minchin
Alan Chapman Whith
John Frederick White
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of PT95338A publication Critical patent/PT95338A/pt
Publication of PT95338B publication Critical patent/PT95338B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
PT95338A 1989-09-20 1990-09-18 Metodo para o tratamento da dor ou de perturbacoes do snc utilizando antagonistas selectivos nos auto-receptores gaba, incluindo derivados de 3,4-di-hidro- ou 1,2,3,4-tetra-hidro-isoquinolina, e processos para a preparacao dos referidos derivados PT95338B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898921304A GB8921304D0 (en) 1989-09-20 1989-09-20 New method of treatment and heterocyclic compounds used therein

Publications (2)

Publication Number Publication Date
PT95338A true PT95338A (pt) 1991-08-14
PT95338B PT95338B (pt) 1998-07-31

Family

ID=10663385

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95338A PT95338B (pt) 1989-09-20 1990-09-18 Metodo para o tratamento da dor ou de perturbacoes do snc utilizando antagonistas selectivos nos auto-receptores gaba, incluindo derivados de 3,4-di-hidro- ou 1,2,3,4-tetra-hidro-isoquinolina, e processos para a preparacao dos referidos derivados

Country Status (10)

Country Link
US (1) US5118690A (pt)
EP (1) EP0419247A3 (pt)
JP (1) JPH03120218A (pt)
KR (1) KR910005866A (pt)
AU (2) AU642428B2 (pt)
CA (1) CA2025719A1 (pt)
GB (2) GB8921304D0 (pt)
HU (1) HUT59125A (pt)
IE (1) IE65619B1 (pt)
PT (1) PT95338B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9127306D0 (en) * 1991-12-23 1992-02-19 Boots Co Plc Therapeutic agents
AU679765B2 (en) * 1993-06-22 1997-07-10 Abbott Gmbh & Co. Kg Isoquinoline derivatives as therapeutic agents
US5389638A (en) * 1993-09-10 1995-02-14 Abbott Laboratories Tetrahydroisoquinolines as alpha-2 antagonists and biogenic amine uptake inhibitors
JP2000507570A (ja) * 1996-03-29 2000-06-20 日本ワイスレダリー株式会社 脳機能改善薬を製造するための1―ベンジル―1,2,3,4―テトラヒドロイソキノリンの使用
EP0934061B3 (en) 1996-07-24 2015-01-21 Warner-Lambert Company LLC Isobutylgaba and its derivatives for the treatment of pain
FR2772760B1 (fr) * 1997-12-22 2000-02-04 Synthelabo Derives de 3-oxazol-5-yl-1-oxo-1,2-dihydroisoquinoleine-4- propanamide, leur preparation et leur application en therapeutique
US5919794A (en) * 1998-05-11 1999-07-06 Virginia Commonwealth University Methods of using pharmaceutical tetrahydroisoquinolines
WO2000044725A1 (de) * 1999-01-28 2000-08-03 Boehringer Ingelheim Pharma Kg Anellierte dihydropyridine und verwendung von anellierten dihydropyridinen für die herstellung von mitteln für die behandlung von epilepsie
FR2800072B1 (fr) * 1999-10-22 2002-01-11 Centre Nat Rech Scient 1-(2-butyrolactones et 2-thiobutyrolactones)-isoquinolines n-substituees utiles comme stimulant de l'activite de l'acide gamma-aminobutyrique et dans le traitement des troubles nerveux et leur procede de preparation
DE10035997A1 (de) * 2000-07-25 2002-02-07 Boehringer Ingelheim Pharma Verwendung von anellierten Dihydropyridinen zur Herstellung von Mitteln für die Behandlung von chronischen Schmerzen
US6476047B2 (en) 2000-07-25 2002-11-05 Boehringer Ingelheim Pharma Kg Anellated dihydropyridines for the treatment of chronic pain
US6576792B2 (en) 2001-05-04 2003-06-10 Eastman Kodak Company 2-halo-1-cycloalkenecarboxamides and their preparation
ES2324231T3 (es) * 2004-12-17 2009-08-03 F. Hoffmann-La Roche Ag Derivados de tieno-piridina como intensificadores alostericos de gaba-b.
JP2008542328A (ja) 2005-06-02 2008-11-27 エフ.ホフマン−ラ ロシュ アーゲー Gaba−bエンハンサーとしての3−メタンスルホニルキノリン
US8008500B2 (en) * 2007-06-08 2011-08-30 General Electric Company Intermediates useful for making tetrabenazine compounds
US8604242B2 (en) * 2008-10-13 2013-12-10 Interquim, S.A. Process for the preparation of optically active (S)-(−)-2-(N-propylamino)-5-methoxytetraline and (S)-(−)-2-(N-propylamino)-5-hydroxytetraline compounds
CN107043371B (zh) * 2017-06-09 2020-02-11 山东大学 β2-AR激动和抗炎双功能生物碱及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA842831A (en) * 1970-05-26 Engel Wolfhard Process for the production of 1-(2-pyridyl)-3,4-dihydro-isoquinolines
GB642286A (en) * 1948-06-28 1950-08-30 Boots Pure Drug Co Ltd Improvements in and relating to the manufacture of isoquinoline derivatives
GB1062899A (en) * 1963-01-22 1967-03-22 Trevor Edmund Thomas Weston Improvements in and relating to therapeutic compositions
GB1145254A (en) * 1965-03-18 1969-03-12 Bristol Myers Co Novel tetrahydroisoquinoline derivatives and a process for the preparation thereof
DE1620496A1 (de) * 1965-03-24 1970-01-02 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen 1-Pyridyl-3,4-dihydroisochinolinen
DE1695886A1 (de) * 1966-06-16 1971-05-06 Thomae Gmbh Dr K 1-(2-Pyridyl)-1,2,3,4-tetrahydroisochinoline und Verfahren zur Herstellung
DE1620549A1 (de) * 1966-06-16 1970-08-20 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Pyridyl-tetrahydroisochinolinen
AR204327A1 (es) * 1973-07-20 1975-12-22 Fujisawa Pharmaceutical Co Procedimiento para la preparacion de derivados de 1,2,3,4-tetrahidroisoquinolina
GB1553230A (en) * 1975-07-28 1979-09-26 Fujisawa Pharmaceutical Co 1 - aminomethyl - 6,7-dihydroxy - 1,2,3,4-tetrahydroisoquinolines and the preparation thereof
DE3308554A1 (de) * 1983-03-10 1984-09-13 Hoechst Ag, 6230 Frankfurt 1-/1,3-dioxolan-2-ylmethyl)-azole, ihre salze, verfahren zu ihrer herstellung und ihre verwendung
BG38182A1 (en) * 1983-06-21 1985-11-15 Ivanova Tocolytic means
HU191548B (en) * 1984-04-11 1987-03-30 Richter Gedeon Vegyeszet Process for the production of 1-cyclohexyl-3,4-dihydro-iziquinoline-derivatives
US4755218A (en) * 1985-12-31 1988-07-05 Monsanto Company Haloacyl 1-substituted-1,2,3,4-tetrahydro-isoquinolines as herbicide antidotes
CA1330560C (en) * 1986-05-21 1994-07-05 Maurits E. A. Vandewalle Di- and tetrahydroisoquinoline derivatives
DE3621413A1 (de) * 1986-06-26 1988-01-07 Boehringer Ingelheim Kg Verwendung carbocyclisch und heterocyclisch annelierter dihydropyridine als cardioprotektive mittel sowie neue heterocyclisch und carbocyclisch anellierte dihydropyridine, verfahren zu deren herstellung und zwischenstufen fuer deren herstellung
IL86131A0 (en) * 1987-04-24 1988-11-15 Boehringer Ingelheim Kg Benzo-and thieno-3,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
GB8800397D0 (en) * 1988-01-08 1988-02-10 Sandoz Ltd Improvements in/relating to organic compounds
JP2772458B2 (ja) * 1993-07-27 1998-07-02 裕典 久野 犬用糞受け器

Also Published As

Publication number Publication date
EP0419247A3 (en) 1992-01-08
AU5212093A (en) 1994-02-10
AU665639B2 (en) 1996-01-11
GB9020441D0 (en) 1990-10-31
JPH03120218A (ja) 1991-05-22
CA2025719A1 (en) 1991-03-21
GB2236674A (en) 1991-04-17
AU642428B2 (en) 1993-10-21
HU905967D0 (en) 1991-03-28
EP0419247A2 (en) 1991-03-27
GB8921304D0 (en) 1989-11-08
US5118690A (en) 1992-06-02
HUT59125A (en) 1992-04-28
KR910005866A (ko) 1991-04-27
PT95338B (pt) 1998-07-31
IE65619B1 (en) 1995-11-01
AU6304490A (en) 1991-03-28
GB2236674B (en) 1994-05-04
IE903394A1 (en) 1991-04-10

Similar Documents

Publication Publication Date Title
DE3679472D1 (de) Verfahren und vorrichtung zum sieben.
DE69328881D1 (de) Telemetriesystem für eine Vorrichtung zum Erkennen und Behandeln von Tachyarrhythmien
DE68924206D1 (de) Verfahren und Einrichtung zum Filtern von Ungültigkeitserklärungsanforderungen.
ATA241289A (de) Vorrichtung zum aufbewahren und zeitpunktgerechten einnehmen von medikamenten
AT397676B (de) Vorrichtung zum sichern von böschungen und hängen
DE68901201D1 (de) Verfahren und vorrichtung zum desodorieren von toilettenraeumen.
DE68907508D1 (de) Verfahren und vorrichtung zum sterilisieren von deckeln.
DE58901201D1 (de) Verfahren und einrichtung zum raschen wiederherstellen des spinnbetriebs.
DE69004297D1 (de) Vorrichtung und Verfahren zum Herstellen von Zigaretten.
DE3686355D1 (de) Verfahren und vorrichtung zum vernichten von kriechendem ungeziefer.
DE3672027D1 (de) Verfahren und vorrichtung zum ausrichten.
DE68903452D1 (de) Vorrichtung zum granulieren und ueberziehen.
EP0419247A3 (en) Selective gaba antagonists, especially isoquinoline derivatives, and their use for treating cns disorders
DE69003608D1 (de) Vorrichtung zum granulieren und ueberziehen.
DE3681009D1 (de) Vorrichtung zum kontinuierlichen sterilisieren und abfuellen.
DE69229896D1 (de) Verfahren und Vorrichtung zum Herstellen von Draht
DE3771416D1 (de) Verfahren und vorrichtung zum mikroloeten.
DE68921669D1 (de) Vorrichtung zum Trocknen und Kristallisieren von Granulat.
DE59507327D1 (de) Vorrichtung zum Mähen, Vertikutieren und/oder Aufsammeln
DE3775645D1 (de) Verfahren und vorrichtung zum reinigen von gold.
DE3874963D1 (de) Verfahren und vorrichtung zum kontinuierlichen dekatieren von geweben.
DE69205788D1 (de) Vorrichtung und Verfahren zum kontinuierlichen Dekatieren von Geweben.
DE68908330D1 (de) Vorrichtung und verfahren zum wiedereinfaerben.
DE59503668D1 (de) Verfahren und Vorrichtung zum Fischen von Plattfischen oder dergleichen
DE3853296D1 (de) Blätterverteilungsverfahren und vorrichtung.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910306

FG3A Patent granted, date of granting

Effective date: 19980408

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19991031